Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
Table 1
General terminology standard for adverse event (CTCAE) version 5.0.
Level
Clinical description
1
Mild: asymptomatic or mild; only clinical or diagnostic; no treatment required
2
Moderate: requires minor, local, or noninvasive treatment; age equivalent instrumental ADL limitation
3
Serious or medically significant but not immediately life-threatening Causes hospitalization or prolongation of hospitalization; disability; self-care ADL limitation
